Most Popular Stocks - AMEX/NASDAQ/NYSE
------- ------- ------- $----------- $----------- Sign in to view additional most popular stocks!

IPO News

Genome sequencing platform Personalis files for a $115 million IPO

Thu, 05/23/2019 - 6:07pm
Personalis which provides a genome sequencing platform for cancer research filed on Thursday with the SEC to raise up to 115 million in an initial public offering The Menlo Park CA based company was founded in 2011 and booked 48 million in sales for the 12 months ended March 31 2019

Severe genetic disease biotech Stoke Therapeutics files for an $86 million IPO

Thu, 05/23/2019 - 4:07pm
Stoke Therapeutics which is developing therapies that increase gene expression to treat severe genetic diseases filed on Thursday with the SEC to raise up to 86 million in an initial public offering The Bedford MA based company was founded in 2014 and plans to list on the Nasdaq under

UFC to IPO: Endeavor Group files for an estimated $500 million public offering

Thu, 05/23/2019 - 1:09pm
Endeavor Group Holdings a global entertainment production company and talent agency filed on Thursday with the SEC to raise up to 100 million in an initial public offering However the deal size is likely a placeholder for an IPO that we estimate could raise more than 500 million

Office REIT Priam Properties files for a $100 million IPO

Thu, 05/23/2019 - 8:08am
Priam Properties a newly formed REIT focused on office properties in the Midwest and Southeast filed on Wednesday with the SEC to raise up to 100 million in an initial public offering The Nashville TN based company was founded in 2018 and plans to list on the NYSE under the symbol

Targeted cancer therapy developer IDEAYA Biosciences prices IPO at $10, below the range

Thu, 05/23/2019 - 7:08am
IDEAYA Biosciences a Phase 1 biotech developing targeted therapies for genetically defined cancers raised 50 million by offering 5 million shares at 10 below the range of 13 to 15 Insiders had intended to purchase up to 35 million of the IPO IDEAYA Biosciences plans to list on the

Cancer biotech Bicycle Therapeutics prices US IPO at $14, the low end of the range

Wed, 05/22/2019 - 9:07pm
Bicycle Therapeutics a Phase 1 biotech developing novel oncology medicines based on bicyclic peptides raised 61 million by offering 4 3 million ADSs at 14 the low end of the range of 14 to 16 160 Insiders had intended to purchase up to 25 million of the IPO 160 The UK based

Rattler Midstream LP prices upsized IPO at $17.50 midpoint

Wed, 05/22/2019 - 5:06pm
Rattler Midstream LP an oil and gas midstream services unit being spun out of Diamondback raised 665 million by offering 38 million units at 17 50 within the range of 16 to 19 The company originally filed to offer 33 3 million units Rattler Midstream LP plans to list on the Nasdaq

Health food and supplements SPAC Fellazo files for a $50 million US IPO

Wed, 05/22/2019 - 10:06am
Fellazo a SPAC targeting the health food and supplement sector in Asia filed on Wednesday with the SEC to raise up to 50 million in an initial public offering The Zhejiang China based company plans to raise 50 million by offering 5 million units at a price of 10 At 10 Fellazo

Chinese ELT provider Meten International files for a $100 million US IPO

Wed, 05/22/2019 - 9:07am
Meten International Education Group which provides English language teaching in China filed on Wednesday with the SEC to raise up to 100 million in an initial public offering The Shenzhen China based company was founded in 2006 and booked 203 million in sales for the 12 months ended

Trimaran Capital SPAC GX Acquisition prices $250 million IPO at $10

Tue, 05/21/2019 - 12:07pm
GX Acquisition a blank check company led by the managing partners of Trimaran Capital Partners raised 250 million by offering 25 million units at 10 160 Each unit consists of one share of Class A common stock and one half 160 of one warrant redeemable at 11 50 per share 160

Merck acquires Peloton Therapeutics for $1.05 billion one day ahead of scheduled pricing

Tue, 05/21/2019 - 7:08am
Peloton Therapeutics a Phase 2 biotech developing small molecule HIF 2a inhibitors for kidney cancer announced on Tuesday that it would be acquired by Merck for 1 05 billion plus up to 1 15 billion in milestone payments It had filed to raise 150 million at a fully diluted post IPO market

Slack changes ticker to WORK ahead of June direct listing

Mon, 05/20/2019 - 5:09pm
Slack Technologies which provides a workplace messaging application amended its direct listing document with the SEC on Monday Slack now plans to list on the NYSE under the symbol WORK It had previously filed to list under the symbol SK The San Francisco CA based company is expected

Consumer-focused SPAC Haymaker Acquisition II files for a $300 million IPO

Mon, 05/20/2019 - 5:08pm
Haymaker Acquisition II the second consumer focused SPAC created by the former CEO of Starwood Hotels filed on Monday with the SEC to raise up to 300 million in an initial public offering The New York NY based company plans to raise 300 million by offering 30 million units at a price